Nantahala Capital Management Acquires 9.99% Stake in Envoy Medical, Inc. (COCH)

Nantahala Capital Management, LLC, alongside its managing members Wilmot B. Harkey and Daniel Mack, has filed a Schedule 13G disclosing a significant new position in Envoy Medical, Inc. (COCH). As of March 31, 2026, the reporting persons are deemed to beneficially own 7,683,798 shares of Class A Common Stock, representing 9.99% of the company's outstanding shares. This total includes 33,798 shares acquirable within 60 days through the exercise of convertible securities. The filing indicates that the shares are held by various funds and separately managed accounts under Nantahala's control. The reporting persons share voting and dispositive power over the entire position. The filing was made under Rule 13d-1(b), certifying that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. This move establishes Nantahala as a major institutional shareholder in the Minnesota-based medical technology firm.